Yan Shi, M.D.
Assistant Professor of Surgery
Positions
- Assistant Professor of Surgery
-
Division of Pediatric Surgery
Baylor College of Medicine
Addresses
- Texas Children’s Hospital (Hospital)
-
6701 Fannin Street
Houston, TX, 77030
United States
Education
- Clinical Fellowship at Zucker School of Medicine at Hofstra
- New Hyde Park, New York
- Pediatric Surgery
- Research Fellowship at Baylor College of Medicine/Texas Children’s Hospital
- Houston, Texas
- Residency at Baylor College of Medicine
- Houston, Texas
- General Surgery
- MD from University of Arkansas for Medical Sciences
- Little Rock, Arkansas
Certifications
- General Surgery
- American Board of Surgery
- Pediatric Surgery
- American Board of Surgery
Professional Interests
- Pediatric surgery
Professional Statement
Dr. Yan Shi is an assistant professor in the Division of Pediatric Surgery. His clinical interests include pediatric surgical oncology, thoracic wall deformities (Nuss procedure), congenital malformations, pilonidal disease, lung lesions and minimally invasive surgery.
Dr. Shi earned his undergraduate degree in cell biology and molecular genetics from the University of Maryland in College Park. He went on to complete a medical degree from the University of Arkansas for Medical Sciences followed by a residency in general surgery at Baylor College of Medicine. During his residency, he completed a fellowship in pediatric surgical oncology research at Baylor College of Medicine and Texas Children’s Hospital. After his residency training, Dr. Shi completed a fellowship in pediatric surgery at Cohen Children’s Medical Center/Northwell Health in Hyde Park, New York.
Dr. Shi was an assistant professor and attending surgeon at Case Western Reserve University/University Hospitals Rainbow Babies and Children’s Hospital in Cleveland, Ohio, before returning to Baylor College of Medicine and Texas Children’s Hospital in 2021.
An avid researcher, Dr. Shi has written several academic papers on topics relating to pediatric malignant tumors, oncology surgery and treatment of solid pediatric tumors. He has also published several noteworthy studies related to the treatment of malignant tumors in children.
Dr. Shi earned his undergraduate degree in cell biology and molecular genetics from the University of Maryland in College Park. He went on to complete a medical degree from the University of Arkansas for Medical Sciences followed by a residency in general surgery at Baylor College of Medicine. During his residency, he completed a fellowship in pediatric surgical oncology research at Baylor College of Medicine and Texas Children’s Hospital. After his residency training, Dr. Shi completed a fellowship in pediatric surgery at Cohen Children’s Medical Center/Northwell Health in Hyde Park, New York.
Dr. Shi was an assistant professor and attending surgeon at Case Western Reserve University/University Hospitals Rainbow Babies and Children’s Hospital in Cleveland, Ohio, before returning to Baylor College of Medicine and Texas Children’s Hospital in 2021.
An avid researcher, Dr. Shi has written several academic papers on topics relating to pediatric malignant tumors, oncology surgery and treatment of solid pediatric tumors. He has also published several noteworthy studies related to the treatment of malignant tumors in children.
Selected Publications
-
Shi Y, Kvasnovsky C, Khan S, Jain S, Sargeant D, Lamoshi A, Prince J, Sathya C. " Impact of the COVID-19 pandemic on trauma activations at a pediatric level 1 trauma center in New York " Pediatr Surg Int. ;
Pubmed PMID: 34264357. -
Kvasnovsky CL, Shi Y, Rich BS, Glick RD, Soffer SZ, Lipskar AM, Dolgin S, Bagrodia N, Hong A, Prince JM, James DE, Sathya C. " Limiting hospital resources for acute appendicitis in children: Lessons learned from the U.S. epicenter of the COVID-19 pandemic " J Pediatr Surg. ;
Pubmed PMID: 32620267. -
Woodfield SE*, Shi Y*, Patel RH, Chen Z, Shah AP, Whitlock RS, Ibarra AM, Larson SR, Sarabia SF, Badachhape A, Starosolski Z, Ghaghada KB, Sumazin P, Annis DA, López-Terrada D, Vasudevan SA. " MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma " Sci Rep. ;
Pubmed PMID: 33536467. -
Jin J, Jin J, Woodfield SE, Patel RH, Jin NG, Shi Y, Liu B, Sun W, Chen X, Yu Y, Vasudevan SA. " Targeting LRH‑1 in hepatoblastoma cell lines causes decreased proliferation " Oncol Rep. ;
Pubmed PMID: 30320362.
Memberships
- American Pediatric Surgical Association
- American Academy of Pediatrics
- American College of Surgeons
Log In to edit your profile